Veradermics’ Oral VDPHL01 Achieved Early, Consistent, and Robust Hair Growth in Positive Phase 2/3 ‘302’ Clinical Trial in Male Pattern Hair Loss
Go back to Veradermics’ Oral VDPHL01 Achieved Early, Consistent, and Robust Hair Growth in Positive Phase 2/3 ‘302’ Clinical Trial in Male Pattern Hair Loss| (NYSE: MANE) | Delayed: 102.79 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $102.79 | 52 Week High | $ | |||
| Open | $102.79 | 52 Week Low | $ | |||
| Day High | $102.79 | P/E | N/A | |||
| Day Low | $102.79 | EPS | $ | |||
| Volume | 26 | |||||
